Codiak BioSciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Codiak BioSciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 3.17 million shares as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2022-11-03
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.17M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.04M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.90M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.69M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2022-09-30 | 3.17M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 3.04M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 2.90M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 2.69M shares 10-K · filed 2022-03-10 |
| 2021-09-30 | 2.56M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 2.65M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 2.71M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 2.56M shares 10-K · filed 2021-03-17 |
| 2020-09-30 | 2.39M shares 10-Q · filed 2020-11-19 |
| 2019-12-31 | 1.69M shares 10-Q · filed 2020-11-19 |